HIV has been reported to be cytotoxic in vitro and in lymph node infection models. Using 20 a computational approach, we found that partial inhibition of transmission which 21 involves multiple virions per cell could lead to increased numbers of live infected cells if 22 the number of viral DNA copies remains above one after inhibition, as eliminating the 23 surplus viral copies reduces cell death. Using a cell line, we observed increased 24 numbers of live infected cells when infection was partially inhibited with the antiretroviral 25 efavirenz or neutralizing antibody. We then used efavirenz at concentrations reported in 26 lymph nodes to inhibit lymph node infection by partially resistant HIV mutants. We 27 observed more live infected lymph node cells, but with fewer HIV DNA copies per cell, 28 relative to no drug. Hence, counterintuitively, limited attenuation of HIV transmission per 29 cell may increase live infected cell numbers in environments where the force of infection 30 is high. 31
Env have also been shown to lead to cell death of infected cells through CD95 mediated 47 apoptosis following T cell activation (Banda et al, 1992; Westendorp et al, 1995a; Westendorp 48 et al, 1995b) . Using SIV infection, it has been shown that damage to lymph nodes due to 49 chronic immune activation leads an environment less conducive to T cell survival (Zeng et al, 50 2012 ). Finally, double strand breaks in the host DNA caused by integration of the reverse 51 transcribed virus results in cell death by the DNA-PK mediated activation of the p53 response 52 (Cooper et al, 2013) . 53
The lymph node environment is conducive to HIV infection due to the presence of infectable 2016) while another study did not (Josefsson et al, 2013) . One explanation for the divergent 70 results is that different cell subsets are infected to different degrees. For example, T cells were 71
shown not to be multiply infected in the peripheral blood compartment (Josefsson et al, 2011) . 72
However, more recent work investigating markers associated with HIV latency in the face of 73 ART found that the average number of HIV DNA copies per cell is greater than one in 3 out of 74 12 individuals in the face of ART in the CD3 positive, CD32a high CD4 T cell subset (Descours 75 et al, 2017). In the absence of suppressive ART, it would be expected that the number of HIV 76 DNA copies per cell would be higher. 77
Multiple viral integration attempts per cell may increase the probability of death. One 78 consequence of HIV mediated death may be that attenuation of infection may increase viral 79 replication by increasing the number of live targets. Indeed, it has been suggested that more 80 attenuated HIV strains result in more successful infections in terms of the ability of the virus to 81 replicate in the infected individual ( Here we experimentally examined the effect of attenuating cell-to-cell spread by using HIV 84 inhibitors. We observed that partially inhibiting infection with drug or antibody resulted in an 85 increase in the number of live infected lymph node cells, experimentally demonstrating for the 86 first time at the cellular level that attenuation of HIV infection can result in an increase in live 87
infected cells under specific infection conditions. 88
Results

89
We introduce a model of infection where each donor to target transmission leads to an infection 90 probability r and death probability q. The probability of infection of a target given λ infecting 91 virions is 1-(1-r) λ (Sigal et al, 2011) . The probability of a cell to be infected and not die after it 92 has been exposed to λ transmitted virions is therefore: 93
(1) 94
This model makes several simplifying assumptions: 1) all transmissions have equal probabilities 95 to infect targets. 2) The probability for a cell to die from each transmission is equal between 96 transmissions. 3) Productive infection and death are independent events. 97
Since antiretroviral drugs lead to a reduction in the number of infecting virions by, for example, 98 decreasing the probability of reverse transcription in the case of reverse transcriptase inhibitors, 99
we introduced a drug strength value d, where d=1 in the absence of drug and d>1 in the 100 presence of drug. In the presence of drug, λ is decreased to λ/d. The drug therefore tunes λ, 101 and if the antiretroviral regimen is fully suppressive, λ/d is expected to be below what is required 102 for ongoing replication. The probability of a cell to be infected and live given drug strength d is 103 therefore: 104
(2) 105 By this model, the probability to be infected and not die P λ depends on the number of virions 106 and has two parameters, r and q, as well as two measurable inputs, λ and d, where d/λ 107 measures the effect of drug relative to infection strength per cell. Analysis of the probability of a 108 cell to survive and be infected as a function of r and q shows that at each drug strength d/λ, P λ 109 increases as the probability of infection r increases, regardless of the probability of death per 110 infection q (Figure 1 ). Whether and how P λ behaves when drug strength d/λ increases depends 111 on parameter values of r and q. A subset of parameter values results in a peak in the number of 112 infected cells at intermediate d/λ, decreasing as drug strength increases further ( Figure 1 ). We 113 refer to such a peak in infected numbers as an infection optimum. As q increases, the cost of 114 multiple infections per cell increases, and the infection optimum shifts to higher d/λ values. A fall 115 from the infection optimum at decreasing d/λ is driven by increasing cell death as a result of 116 increasing infection attempts per cell. This slope is therefore shallower, and peaks broader, at 117 low q values ( Figure 1 ). 118
Given that an infection optimum is dependent on parameter values, we next tested whether 119 these parameter values occur experimentally in HIV infection. We therefore first tested for an 120 infection optimum in the RevCEM cell line engineered to express GFP upon HIV Rev protein 121 expression (Wu et al, 2007) . We subcloned the cell line to obtain clone E7 which maximized the 122 frequency of GFP positive cells upon infection (Boullé et al, 2016) . 123
We needed to detect the number of integration attempts per cell λ. To estimate this, we used 124 To investigate the effect of multiple infection attempts per cell, we used coculture infection, 135
where infected (donor) cells are co-incubated with uninfected (target) cells and lead to cell-to-136 cell spread. Live infected target cells were assayed after 2 days in coculture with infected 137 donors. Live infected cells were identified based on the absence of cell death indicator dye 138 DRAQ7 fluorescence, and presence of GFP ( Figure 2A ). We used approximately 2% infected 139 donor cells as our input, and detected the number of HIV DNA copies per cell by sorting 140 individual cell and splitting the individual cell lysates over 10 wells of an agarose gel ( Figure 2B) . 141
We obtained a wide distribution of viral DNA copies per cell, ranging from 0 to 8 ( Figure 2C ). We 142 computationally corrected the detected number of DNA copies for the sensitivity of our PCR 143 reaction as determined by the ACH-2 results (Materials and Methods). On average we obtained 144 14 copies per cell after correction. 145
To tune λ, we added the HIV reverse transcriptase inhibitor efavirenz (EFV) to infections. To 146 calculate d, we used cell-free infection, which we verified results in single integrations per cell 147 ( Figure 2D 2011)), equivalent to the fraction of unaffected cells in a previously described approach 151 modelling the infection response to inhibitor with two parameters: the 50% inhibitory drug 152 concentration (IC 50 ) and the Hill coefficient for drug action (Shen et al, 2008) . We fitted the 153 observed response of infection to EFV to using this approach to estimate d across a range of 154 EFV concentrations. The best fit of the model to the cell-free data using EFV sensitive HIV 155 showed a monotonic decrease with IC 50 =2.9nM and Hill coefficient of 2.1 ( Figure 2D , black line). 156
We next dialled in EFV to tune λ/d in coculture infection. We observed a peak in the number of 157 live infected target cells at 4nM EFV ( Figure 2E ). Equation (2) best fit the behaviour of infection 158 when r =0.4 and q =0.11 ( Figure 2E , black line). Hence an infection optimum is present in the 159 cell line infection system. 160
We repeated the experiment with EFV resistant HIV. To derive the resistant mutant, we cultured 161 EFV sensitive HIV in our reporter cell line in the presence of EFV. We obtained the L100I 162 partially resistant mutant. We then replaced the reverse transcriptase of the wild type molecular 163 clone with the mutant reverse transcriptase gene (Materials and Methods). We derived d mut for 164 the L100I mutant using cell-free mutant infection ( Figure 3A for logarithmic y-axis plot). L100I mutant was found to have an IC 50 =29nM EFV and Hill 166 coefficient of 2.0 ( Figure 3A , black line). 167
We next performed coculture infection. Like with wild type HIV coculture infection, there was a 168 peak in the number of live infected target cells for the L100I mutant infection, but it was shifted 169 to 80nM EFV ( Figure 3B ), an EFV concentration which a decreased cell-free mutant infection 170 approximately 9-fold and λ/d mut ~2. Fits were obtained to Equation (2) using d mut values and λ 171 measured for wild type infection. The fits recapitulated the experimental results when r =0.9 and 172 q =0.06 ( Figure 3B , black line). 173
In order to examine whether a peak in live infected targets can be obtained with an unrelated 174 inhibitor, we used the HIV neutralizing antibody b12. This antibody is effective against cell-to-175 cell spread of HIV (Baxter et al, 2014; Reh et al, 2015). We obtained a peak with 5ug/ml b12 176 ( Figure 4 ). The b12 concentration that resulted in a peak number of live infected cells was the 177 same for wild type virus and the L100I mutant, showing L100I mutant fitness gain was EFV 178
specific. 179
While the RevCEM cell line is a useful tool to illustrate the principles governing the formation of 180 an infection optimum, the sensitivity of such an optimum to parameter values would make its 181 presence in primary HIV target cells speculative. We therefore investigated whether a fitness 182 optimum occurs in primary human lymph node cells, the anatomical site of which would be most 183 likely associated with a high force of infection. We derived human lymph nodes from HIV 184 negative individuals from indicated lung resections (S Table 1 ), cellularized the lymph node 185 tissue, and infected the resulting lymph node cells with HIV by coculture infection. A fraction of 186 the cells was infected by cell-free and used as infected donor cells. We added these to 187 uninfected target cells from the same lymph node, and detected the number of live infected cells 188 after 4 days of infection with the L100I EFV resistant mutant in the face of EFV. We detected the 189 number of live infected cells by the exclusion of dead cells with the death detection dye 190 eFluor660 followed by single cell staining for HIV Gag using anti-p24 antibody ( Figure 5A ). 191
In each of the lymph nodes tested, we observed a peak in live infected cells at intermediate EFV 192
concentrations. The infection optimum in the lymph node of participant 205 was visible as a 193 plateau between 50 and 200 nM EFV ( Figure 5A , first row). The lymph node from participant 194 251 showed a peak at 100nM EFV ( Figure 5A , second row). In the presence of EFV, there was 195 a decrease in the fraction of dead cells that was offset by a similar increase in the fraction of live 196 infected cells for lymph nodes from both participants. There were more overall detectable cells 197 with EFV, resulting in differences in the absolute concentrations of live infected cells being 198 larger than the differences in the fractions of live infected cells between EFV and non-drug 199 treated cells ( Figure 5A , with absolute number of live infected cells shown in parentheses in the 200 flow cytometry plots). This is most likely due to cells which died early becoming fragments and 201 so being excluded from the total population in the absence of EFV. 202
We used a lymph node from a third individual, where we obtained more cells, to examine the 203 number of HIV DNA copies per cell. This lymph node also showed an infection optimum at 204 50nM EFV ( Figure 5A , third row). To detect the effect of EFV on integrations per cell, we sorted 205 single cells based on p24 positive signal, de-crosslinked to remove the fixative (Materials and 206 Methods), then divided each cell into 4 wells. As with the cell line, we detected HIV DNA copies 207 by PCR 48 hours post-infection. We observed multiple DNA copies in EFV untreated lymph 208 node cells. The number of copies decreased with EFV ( Figure 5B ). We corrected for sensitivity 209 of detection as quantified in ACH-2 cells (Materials and Methods). The corrected numbers were 210 21 HIV DNA copies with no drug, and 5 copies in the presence of EFV at the infection optimum 211 can be expected to shift to even higher EFV concentrations with more resistant mutants. As 270 EFV has a longer half-life than the other antiretrovirals co-formulated with it, it may be the only 271 agent present in partially adherent individuals for substantial periods of time (Taylor et al, 2007) . 272
Therefore, partial inhibition of HIV infection with EFV may provide a surprising advantage to 273 EFV resistant mutants, and may allow individuals failing therapy to better transmit drug resistant 274 strains. 275 For a cell-free infection of E7 RevCEM and lung lymph node cells, 10 6 cells/ml were infected 301 with 2x10 8 NL4-3 viral copies/ml (~20ng p24 equivalent) for 2 days. For coculture infection, 302
Materials and Methods
infected cells from the cell-free infection were used as the donors and cocultured with target 303 cells. For E7 RevCEM, 2% infected donor cells were added to uninfected targets and cocultured 304 for 2 days. For lymph node cells, a ratio of 1:4 donor to targets cells was used and infection 305 incubated for 4 days. 
Determination of HIV DNA copy number in individual cells 327
Plates were thawed at room temperature and spun down. Fixed cells were de-crosslinked by 328 incubating in a thermocycler at 56 ᴼ C for 1 hour. The lysate from each well was split equally over 329 10 wells (2.5µl each well after correction for evaporation) for E7 RevCEM or 4 wells (6.8µl each 330 well after correction for evaporation) for lymph nodes, containing 50µl of Phusion hot start II 331 DNA polymerase (New England Biolabs) PCR reaction mix (10µl 5X Phusion HF buffer, 1µl 332 dNTPs, 2.5µl of the forward primer, 2.5µl of the reverse primer, 0.5µl Phusion hot start II DNA 333 polymerase, 2.5µl of DMSO and molecular biology grade water to 50µl reaction volume). Two 334 rounds of PCR were performed. The first round reaction amplified a 700bp region of the reverse 335 transcriptase gene using the forward primer 5' CCTACACCTGTCAACATAATTGGAAG 3' and 336 reverse primer 5' CATCAGAAAGAACCTCCATTC 3'. Cycling program was 98ᴼC for 30 337 seconds, then 34 cycles of 98ᴼC for 10 seconds, 63ᴼC for 30 seconds and 72ᴼC for 15 seconds 338 with a final extension of 72ᴼC for 5 minutes. 1µl of the first round product was then transferred 339 into a PCR mix as above, with nested second round primers (forward 5' 340 TAAAAGCATTAGTAGAAATTTGTACAGA 3', reverse 5' CATCTGTTGAGGTGGGGATTTACC 341 3'). The second round PCR amplified a 550bp product which was then visualized on a 1% 342 agarose gel. PCR reactions were found to work best if sorted plates were thawed no more than 343 once, and plates which underwent repeated freeze-thaw cycles showed poor amplification. If an element existed with a value between σ/w+ε and 2(σ/w), the second well was occupied, 355 and if between (σ/w+ε)(n-1) and n(σ/w), the nth well was occupied. The sum of wells occupied 356 at least once was determined, and the process repeated j times for each λ, where j was the 357 number of cells in the experimental data. A least squares fit was performed to select λ which 358 best fit the experimental results across well frequencies, and mean and standard deviation for λ 359 was derived by repeating the simulation 10 times. 360 361
Fit of the EFV response for single infections using IC 50 and Hill coefficient 362
To obtain d, we normalized Equation (2) by the fraction of infected cells in the absence of drug 363 (Sigal et al, 2011) to obtain Tx = (infected targets with EFV)/ (infected targets no EFV)= ((1-(1-364 r) λ/d ) (1-q) λ/d )/ ((1-(1-r) λ ) (1-q) λ ). We approximate the result at small r, q to Tx = (1-e -rλ/d ) e -qλ/d / (1-365 e -rλ ) e -qλ = e qλ (1-1/d) ((1-e -rλ/d ) / (1-e -rλ ) ). Expanding the exponentials we obtain Tx = (1+qλ(1-1/d) ) 366 ((-rλ/d)/-rλ) = (1+qλ(1-1/d)) (1/d). We note that at λ<1, qλ (1-1/d Chun 
